These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7777576)

  • 1. The carboxyl-terminal domain of the p53 protein regulates sequence-specific DNA binding through its nonspecific nucleic acid-binding activity.
    Bayle JH; Elenbaas B; Levine AJ
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5729-33. PubMed ID: 7777576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmented DNA-binding activity of p53 protein encoded by a carboxyl-terminal alternatively spliced mRNA is blocked by p53 protein encoded by the regularly spliced form.
    Wolkowicz R; Peled A; Elkind NB; Rotter V
    Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6842-6. PubMed ID: 7624329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases.
    Takenaka I; Morin F; Seizinger BR; Kley N
    J Biol Chem; 1995 Mar; 270(10):5405-11. PubMed ID: 7534296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 domains: identification and characterization of two autonomous DNA-binding regions.
    Wang Y; Reed M; Wang P; Stenger JE; Mayr G; Anderson ME; Schwedes JF; Tegtmeyer P
    Genes Dev; 1993 Dec; 7(12B):2575-86. PubMed ID: 8276240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternatively spliced forms in the carboxy-terminal domain of the p53 protein regulate its ability to promote annealing of complementary single strands of nucleic acids.
    Wu L; Bayle JH; Elenbaas B; Pavletich NP; Levine AJ
    Mol Cell Biol; 1995 Jan; 15(1):497-504. PubMed ID: 7528329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific DNA binding by different classes of human p53 mutants.
    Rolley N; Butcher S; Milner J
    Oncogene; 1995 Aug; 11(4):763-70. PubMed ID: 7651740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of mutant p53 temperature-sensitive DNA binding.
    Friedlander P; Legros Y; Soussi T; Prives C
    J Biol Chem; 1996 Oct; 271(41):25468-78. PubMed ID: 8810317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.
    Bargonetti J; Manfredi JJ; Chen X; Marshak DR; Prives C
    Genes Dev; 1993 Dec; 7(12B):2565-74. PubMed ID: 8276239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of p53 DNA binding activity by point mutation.
    Marston NJ; Ludwig RL; Vousden KH
    Oncogene; 1998 Jun; 16(24):3123-31. PubMed ID: 9671391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A DNA binding domain is contained in the C-terminus of wild type p53 protein.
    Foord OS; Bhattacharya P; Reich Z; Rotter V
    Nucleic Acids Res; 1991 Oct; 19(19):5191-8. PubMed ID: 1923804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling to p53: breaking the posttranslational modification code.
    Appella E; Anderson CW
    Pathol Biol (Paris); 2000 Apr; 48(3):227-45. PubMed ID: 10858956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops.
    Stros M; Muselíková-Polanská E; Pospísilová S; Strauss F
    Biochemistry; 2004 Jun; 43(22):7215-25. PubMed ID: 15170359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species-specific regulation of alternative splicing in the C-terminal region of the p53 tumor suppressor gene.
    Laverdière M; Beaudoin J; Lavigueur A
    Nucleic Acids Res; 2000 Mar; 28(6):1489-97. PubMed ID: 10684946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific DNA binding by p53 is independent of mutation at serine 389, the casein kinase II site.
    Rolley N; Milner J
    Oncogene; 1994 Oct; 9(10):3067-70. PubMed ID: 8084615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro.
    Hainaut P; Milner J
    Cancer Res; 1993 Oct; 53(19):4469-73. PubMed ID: 8402615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of p53 with its consensus DNA-binding site.
    Wang Y; Schwedes JF; Parks D; Mann K; Tegtmeyer P
    Mol Cell Biol; 1995 Apr; 15(4):2157-65. PubMed ID: 7891710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The requirement of the carboxyl terminus of p53 for DNA binding and transcriptional activation depends on the specific p53 binding DNA element.
    Zhang W; Guo XY; Deisseroth AB
    Oncogene; 1994 Sep; 9(9):2513-21. PubMed ID: 8058314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The N terminus of the murine p53 tumour suppressor is an independent regulatory domain affecting activation and thermostability.
    Hansen S; Lane DP; Midgley CA
    J Mol Biol; 1998 Jan; 275(4):575-88. PubMed ID: 9466932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities and response to DNA damage of latent and active sequence-specific DNA binding forms of mouse p53.
    Wu Y; Huang H; Miner Z; Kulesz-Martin M
    Proc Natl Acad Sci U S A; 1997 Aug; 94(17):8982-7. PubMed ID: 9256421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the p53 core domain dimer bound to DNA.
    Ho WC; Fitzgerald MX; Marmorstein R
    J Biol Chem; 2006 Jul; 281(29):20494-502. PubMed ID: 16717092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.